Generation of an induced pluripotent stem cell line (TRNDi003-A) from a Noonan syndrome with multiple lentigines (NSML) patient carrying a p.Q510P mutation in the PTPN11 gene

被引:8
|
作者
Li, Rong [1 ]
Baskfield, Amanda [1 ]
Lin, Yongshun [2 ]
Beers, Jeanette [2 ]
Zou, Jizhong [2 ]
Liu, Chengyu [3 ]
Jaffre, Fabrice [4 ]
Roberts, Amy E. [5 ]
Ottinger, Elizabeth A. [1 ]
Kontaridis, Maria I. [6 ,7 ,8 ]
Zheng, Wei [1 ]
机构
[1] NIH, Natl Ctr Adv Translat Sci, 9800 Med Ctr Dr, Bethesda, MD 20892 USA
[2] NHLBI, IPSC Core, NIH, Bldg 10, Bethesda, MD 20892 USA
[3] NHLBI, Transgen Core, NIH, Bldg 10, Bethesda, MD 20892 USA
[4] Weill Cornell Med Coll, Dept Surg, New York, NY USA
[5] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA
[6] Beth Israel Deaconess Med Ctr, Div Cardiol, Dept Med, Boston, MA 02215 USA
[7] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[8] Mason Med Res Inst, 2150 Bleecker St, Utica, NY 13501 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1016/j.scr.2018.101374
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Noonan syndrome with multiple lentigines (NSML), formerly known as LEOPARD Syndrome, is a rare autosomal dominant disorder. Approximately 90% of NSML cases are caused by missense mutations in the PTPN11 gene which encodes the protein tyrosine phosphatase SHP2. A human induced pluripotent stem cell (iPSC) line was generated using peripheral blood mononuclear cells (PBMCs) from a patient with NSML that carries a gene mutation of p.Q510P on the PTPN11 gene using non-integrating Sendai virus technique. This iPSC line offers a useful resource to study the disease pathophysiology and a cell-based model for drug development to treat NSML.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Generation of an induced pluripotent stem cell line, ICGi028-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.E510Q mutation in HADHA
    Dementyeva, E. V.
    Vyatkin, Yu. V.
    Chernyavsky, A. M.
    Zakian, S. M.
    STEM CELL RESEARCH, 2021, 53
  • [22] Generation of an induced pluripotent stem cell line SYSUi-003-A from a child with epilepsy carrying GRIN2A mutation
    Sun, Chuanbo
    Yang, Mingzhu
    Qin, Fengying
    Guo, Ruirui
    Liang, Shiqi
    Hu, Hao
    STEM CELL RESEARCH, 2020, 43
  • [23] Generation of an induced pluripotent stem cell (iPSC) line (HIHDNEi003-A) from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Thr374Ala) mutation
    Uysal, Betuel
    Loeffler, Heidi
    Rosa, Filip
    Lerche, Holger
    Schwarz, Niklas
    STEM CELL RESEARCH, 2019, 40
  • [24] Generation of an induced pluripotent stem cell line (TRNDi004-I) from a Niemann-Pick disease type B patient carrying a heterozygous mutation of p.L43_A44delLA in the SMPD1 gene
    Baskfield, Amanda
    Li, Rong
    Beers, Jeanette
    Zou, Jizhong
    Liu, Chengyu
    Zheng, Wei
    STEM CELL RESEARCH, 2019, 37
  • [25] Generation of an induced pluripotent stem cell line from an Ohtahara syndrome patient with the hemizygous mutation p.Q503Afs*28 (c.1507_1508del) in the ARX gene
    Wang, Chunmei
    Wang, Yilin
    Xu, Wuhen
    Lin, Xuefeng
    Xi, Jiaming
    Wang, Simei
    Lin, Longlong
    Yuan, Fang
    Wang, Anqi
    Wang, Chao
    Luo, Xiaona
    Xu, Quanmei
    Yin, Rongrong
    Zhang, Yuanfeng
    Huang, Xiaoyi
    Chen, Yucai
    STEM CELL RESEARCH, 2022, 59
  • [26] Generation of a human induced pluripotent stem cell line from a patient diagnosed with schizophrenia carrying a 16p11.2 deletion
    Madencioglu, Deniz A.
    Kruth, Karina
    Shin, Mallory
    Andreasen, Nancy
    Wassink, Thomas
    Williams, Aislinn
    STEM CELL RESEARCH, 2022, 59
  • [27] Generation of an induced pluripotent stem cell line (SJTUGHi003-A) from a patient with Sorsby fundus dystrophy carrying c.484G>A mutation in TIMP3 gene
    Zhu, Xinyue
    Tang, Lu
    Zhang, Ting
    Bai, Xinyue
    Chen, Jieqiong
    Zhang, Lei
    Gong, Yuanyuan
    Jiang, Mei
    Sun, Xiaodong
    STEM CELL RESEARCH, 2024, 77
  • [28] Generation of a human induced pluripotent stem cell (iPSC) line from a Bernard-Soulier syndrome patient with the mutation p.Asn45Ser in the GPIX gene
    Lopez-Onieva, Lourdes
    Machuca, Candela
    Lamolda, Mar
    Montes, Rosa
    Luisa Lozano, Maria
    Vicente, Vicente
    Rivera, Jose
    Ramos-Mejia, Veronica
    Real, Pedro J.
    STEM CELL RESEARCH, 2016, 17 (03) : 603 - 606
  • [29] Generation of an induced pluripotent stem cell line (TRNDi030-A) from a patient with Farber disease carrying a homozygous p. Y36C (c. 107 A>G) mutation in ASAH1
    Brooks, Brianna M.
    Yeh, Charles D.
    Beers, Jeanette
    Liu, Chengyu
    Cheng, Yu-Shan
    Gorshkov, Kirill
    Zou, Jizhong
    Zheng, Wei
    Chen, Catherine Z.
    STEM CELL RESEARCH, 2021, 53
  • [30] Generation of a human induced pluripotent stem cell (iPSC) line from skin fibroblasts of a patient carrying an E363Q mutation in PSEN1 gene
    Zhu, Wanwan
    Zhou, You
    Wang, Qingyu
    Li, Jie
    Chu, Shanshan
    Jin, Wei
    Mao, Chenhui
    Dong, Liling
    Gao, Jing
    Xu, Qi
    STEM CELL RESEARCH, 2022, 61